Regarding “Surgical treatment of nonaneurysmal aortic arch lesions in patients with systemic embolizations”  by Safi, Hazim J. et al.
Regarding “Surgical treatment of nonaneurysmal
aortic arch lesions in patients with systemic
embolizations”
Hazim J. Safi, MD, Charles C. Miller III, PhD, and Anthony L. Estrera, MD, Houston, Tex
The medical community has often underestimated the
significance of atheromatous aortic disease of the aortic
arch and proximal descending aorta. The carotid arteries,
chambers of the heart, and heart valves were the earliest
recognized sources of emboli that can travel to the brain.
But in the early 1990s, autopsy studies and the recently
introduced transesophageal echocardiography (TEE) veri-
fied earlier suspicions of the arch as a significant source. The
incidence rate of atheromatous aortic disease may be as
high as 12% in populations with a history of any atheroscle-
rotic disease, as reported in a study evaluating transesoph-
ageal echocardiography.1 And in patients over 60 years old
with a history of cerebrovascular disease, an incidence rate
as high as 60% has been reported.2 In addition to increasing
the risk of stroke, atheromatous aortic disease is a marker
for severe systemic atherosclerotic disease, commonly re-
sponsible for acute coronary artery syndromes, renovascu-
lar disease, and peripheral arterial occlusive disease.
Severe atheromatous aortic disease and plaquing por-
tend a poor long-term outcome.3-5 Whether diminished
long-term survival is the direct result of chronic distal
embolization or just a harbinger of multiple comorbid
conditions is unknown. Few studies have looked at the
success of surgical management of patients presenting with
peripheral emboli and nonaneurysmal aortic arch lesions.
The report by Goueffic et al in this issue of the Journal
addresses this significant problem.6 A survey was mailed to
cardiovascular surgeons at 17 French cardiovascular cen-
ters. Thirty-eight patients (19 male and 19 female) were
identified retrospectively who had had surgical intervention
for nonaneurysmal disease of the proximal aorta (ascend-
ing, transverse arch, and proximal descending aorta) for the
purpose of preventing systemic embolization. Dates of
surgery spanned a 20-year period. Atheromata were iden-
tified and severity graded with TEE, magnetic resonance
imaging, computed tomography, or angiography. The au-
thors appropriately report the diagnostic modalities used to
identify and characterize atheromatous plaques but, no
doubt limited by their data source, were only able to
describe the general qualities of the plaque (sessile, pro-
truding, or mobile). Specific grades of atheromatous dis-
ease, which have been demonstrated to have prognostic
significance, were not reported.
Currently, TEE is the most frequently used diagnostic
modality and the technique that we prefer. Plaque grading
with TEE depends on the morphology, and grading is
assigned in relation to the thickness of the plaque: grade I,
less than 1 mm; II, 1 to 3.9 mm; III, more than 4.0 mm;
and IV, any plaque size with a freely mobile component.
Aortic plaquing of grade III or IV identified with TEE
predicts embolization and diminished long-term survival.7
We have also correlated the findings of TEE with patho-
logic examination of aortic wall specimens and found TEE
to be consistently accurate.8 Used intraoperatively, TEE
can help to lower the incidence of stroke, with the surgeon
better able to navigate placement of catheters and clamps
and to avoid loosening of atherosclerotic plaques.
Goueffic et al use Dubost’s classification to designate
the location of the atheroma. Patients were divided into
two groups: group 1, with lesions proximal to the left
subclavian artery; and group II, with lesions at the origin of,
and proximal to, the left subclavian artery and the proximal
descending aorta. Surgical management varied both within
and between groups I and II and included thrombectomy
and endarterectomy, resection and graft replacement, and
patch aortoplasty. Both median sternotomy (10/15) and
posterior lateral thoracotomy (5/15) were used for the
approach in group I, and lateral thoracotomy (20/22) was
used predominantly for group II. The aorta was clamped in
34 patients. Profound hypothermia was used in a total of
eight patients.
In our own approach to surgical treatment of the
ascending aorta and arch, all resections involve cardiopul-
monary bypass and profound hypothermic circulatory ar-
rest. Embolization may occur at any time during cardiopul-
monary bypass, so we apply minimal aortic manipulation.
Clamping is not performed until after the diseased aorta has
been resected. We employ profound hypothermic circula-
tory arrest with the cerebral protective adjunct of retro-
grade cerebral perfusion (RCP) via the superior vena cava
for most cases involving the transverse aortic arch. The
general benefits of RCP include the ability to provide
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uniform cerebral cooling, flushing of atheromatous debris,
and possible nutrient flow.
The authors found that group II lesions—proximal to
the left subclavian artery to the proximal descending aor-
ta—were managed predominantly with aortic clamping and
partial bypass via a lateral thoracotomy. In such cases,
because of the concern of dislodging atheromatous plaque
during clamping, we approach the distal transverse aortic
arch and proximal descending thoracic aortic lesions via a
median sternotomy with profound hypothermic circulatory
arrest and RCP. This also allows minimal manipulation of
the diseased aorta. We avoid clamping the aorta proximal to
the subclavian artery, especially if severe atheromatous
plaque is located in this area, because of the increased
potential for neurologic injury. With these techniques dur-
ing repairs of the ascending and transverse aortic arch, we
have been able to achieve a stroke rate of 1.1%.9 If severe
diffuse atheromatous disease is identified in the proximal
descending thoracic aorta, we insert a tube graft, separate
from the ascending and transverse aortic graft, into the
descending thoracic aorta to prevent atheromatous debris
from embolizing to the cerebral circulation (modified ele-
phant trunk technique).
In the case of an atheromatous plaque isolated to the
descending thoracic aorta, we use TEE to verify the exact
location in the aorta. Only if the location of the plaque is
sufficiently distal to the subclavian artery (several centime-
ters) and a clamp can be safely applied do we approach this
lesion via a modified thoracoabdominal incision.
In Goueffic’s report, follow-up was achieved in 34/38
patients for a mean period of 30 months. Pathologic spec-
imens of the aorta were compared with the preoperative
radiographic and echocardiographic examinations. An ex-
cellent mortality rate of 2.6% was achieved in this younger
population (mean, 49 years) with a morbidity rate of
28.9%. Neurologic complications, observed in 15.8% (6/
38) of patients, accounted for the majority. It should be
noted that if nerve injuries (two phrenic nerve and one
recurrent laryngeal nerve) are excluded, then the incidence
rate of cerebrovascular deficits was 8.8%. All patients were
discharged on either anticoagulants or antiplatelet medica-
tions. Ultimately, four patients (11.8%) developed recur-
rence of an embolic event.
Despite resection of the suspected atheromatous dis-
ease and concurrent treatment with anticoagulation, the
recurrence rate was significant. Another study reporting the
results of surgical therapy noted an even higher rate of
recurrent embolic events (50%) in surgically treated pa-
tients.10 Although one might surmise that surgically resect-
ing the atheromatous plaque should eliminate the source of
emboli, it is difficult to demonstrate that the actual origin of
the emboli is from the diseased aorta. Thus, unless the
entire aorta is removed, the risk of recurrence remains.
The authors correctly emphasize the importance of
anticoagulation for the treatment of this problem. All pa-
tients with suspected embolization from atheromatous aor-
tic disease are started on anticoagulation. Patients who are
refractory to anticoagulation and develop a recurrence of
embolization should be considered for surgical interven-
tion, with more aggressive recommendations for patients
with severe (grades III or IV) atheromatous disease. Med-
ical management includes anticoagulation with the possible
addition of platelet inhibitors. We prefer oral anticoagula-
tion since platelet inhibitors alone have been shown to have
a higher rate of recurrent emboli when compared with oral
anticoagulation.1
The authors are to be commended for providing us
with new insight into the treatment of the difficult problem
of atheromatous aortic disease. Because few studies address
this problem, the optimal management—whether medical
or surgical—is not yet clarified. Atheromatous aortic dis-
ease is likely underestimated in the general population, and
the prognosis for long-term survival in untreated patients is
poor. While we all look forward to larger prospective stud-
ies in the future, it is important in the meantime to learn as
much as we can by gleaning results from existing sources.
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Please see related article by Dr Goue¨ffic et al on pages
1186-93.
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